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CORRESPONDENCE
Kounis syndrome: Aspects of 
incidence and epidemiology 
To the Editor: Kounis syndrome is a hypersensitivity coronary 
disorder induced by environmental factors, foods, drugs, conditions 
and stents. It manifests as coronary spasm, acute myocardial 
infarction and stent thrombosis, and affects the cerebral, mesenteric 
and coronary arteries. Allergic, hypersensitivity, anaphylactic 
and anaphylactoid reactions are associated with this syndrome. 
Kounis syn drome has been observed in every race, age group 
(2 - 90  years) and geographical location.[1] It is not a rare disease, 
but it is infrequently reported in clinical practice because of missed, 
unrecognised and/or undiagnosed cases. Furthermore, there is a 
paucity of large prospective trials, determining its prevalence and 
exact incidence. In a very interesting report published in the SAMJ[2] 
a 39-year-old man with a previous history of exercise-induced 
asthma and allergy to cefixime developed type I Kounis syndrome 
following an allergic reaction to ciprofloxacin. The authors correctly 
commented on the paucity of data concerning the incidence and 
prevalence of Kounis syndrome in South Africa and elsewhere. 
We therefore consider the following aspects on its incidence and 
epidemiology to be of additional value: 
The incidence of anaphylaxis with circulatory symptoms is 
estimated at 7.9 - 9.6/100 000 inhabitants per year with a case fatality 
rate of 0.0001%.[3] 
In the only retrospective study published so far, the incidence of 
Kounis syndrome at emergency departments in 1 year among all 
admissions and allergy patients was 19.4/100 000 (27/138 911) and 
3.4% (27/793), respectively.[4] 
Of the 51 cases of Kounis syndrome reported to the International 
Pharmacovigilance Agency (VigiBase) in the period 2010 - 2014, 
almost half (22 reports) were in 2014. Most cases occurred in the 
USA, and non-steroidal anti-inflammatories were the most frequent 
trigger drugs.[5] 
Kounis syndrome prevalence was estimated to be at 0.002% in the 
catheterisation laboratory of a tertiary hospital in Istanbul, Turkey.[6]
The annual incidence of Kounis syndrome in the district of Achaia, 
Greece, with a population of 300 000 inhabitants, was estimated at 
4.33 cases/100 000 inhabitants.[7] 
Troponin levels were found to be significantly raised in 31 
patients admitted to the emergency department and suffering 
from anaphylaxis, angioedema, urticaria and urticaria-angioedema 
in comparison with 125 healthy controls. Systematic troponin 
measurement in patients with acute allergic reactions is advisable in 
order to detect and treat potential myocardiac injury.[8] 
Finally, in 300 anaphylaxis cases, myocardial injury was present 
in 7.3% of patients. Various cardiomyopathies, including Kounis 
syndrome and Takotsubo cardiomyopathy, were also observed in 
patients with myocardial injury.[9] 
All the above denotes that the incidence of Kounis syndrome is higher 
that it has been estimated so far. Kounis syndrome has mostly been 
encountered in southern Europe, especially Turkey, Greece, Italy and 
Spain.[10] This geographical variation could be attributed to the increased 
awareness of physicians of the existence of Kounis syndrome, climate 
and environmental conditions that result in pollen cross-reactivities and 
hymenoptera exposures, overconsumption of medicines, or inadequacy 
of preventative measures. It is anticipated that with increased awareness 
of the existence of Kounis syndrome and the conducting of large 
prospective trials, the true estimation of its incidence will be achieved.
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